About this trial
This Phase I randomized clinical trial aims to investigate the short-term effects of three commonly prescribed statins (atorvastatin, rosuvastatin, and simvastatin) at different dose levels on blood glucose homeostasis in healthy volunteers. The study will assess changes in fasting blood glucose, insulin, and C-peptide levels following two days of statin administration under controlled conditions. The research seeks to provide comparative data on the potential diabetogenic effects of these medications.
Eligibility criteria
Qualifiers
healthy volunteers
Non diabetic
blood glucose level (less than140 mg/dl)
Disqualifiers
Participants with a history of diabetes mellitus
With chronic diseases e.g heart disease, kidney disease
participants taking other medications
Trial design
Treatments tested in this trial
- Simvastatin (10mg, 20mg, 40mg)
- Rosuvastatin (5mg, 20mg, 40mg)
- Atorvastatin (10mg, 20mg, 40mg)
Treatment groups
Sponsors and collaborators
Shaheed Benazir Bhutto University Sheringal Dir Upper
Lead sponsor
Khyber Medical University Peshawar
Collaborator